TNFalpha blockade in human diseases: mechanisms and future directions. - Wikidata - wikimedia - TriplyDB

TNFalpha blockade in human diseases: mechanisms and future directions.

TNFalpha blockade in human diseases: mechanisms and future directions.

http://www.wikidata.org/entity/Q36536886

about

Cherubism: best clinical practice Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation Use of the tumor necrosis factor-blockers for Crohn's disease Mast cell modulation of the vascular and lymphatic endothelium Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis The protective antibodies induced by a novel epitope of human TNF-alpha could suppress the development of collagen-induced arthritis.Phospholipase D1 mediates TNFalpha-induced inflammation in a murine model of TNFalpha-induced peritonitis.CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells TNF and MAP kinase signalling pathways.Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo.Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment.Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.The effect of Astragalus extractive on alveolar bone rebuilding progress of tooth extracted socket of ovariectomied rats Small-molecule inhibitors of the interaction between TNF and TNFR.TLR and TNF-R1 activation of the MKK3/MKK6-p38α axis in macrophages is mediated by TPL-2 kinase.Drug free remission after steroid-dependent disappearance of lymphoproliferative disorder in rheumatoid arthritis patient treated with TNF-alpha blockade: case study.Melatonin attenuates inflammation of acute pulpitis subjected to dental pulp injury.Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α.Adipokines as drug targets in diabetes and underlying disturbances.Biologics in paediatric Crohn's disease.Validation of the cantharidin-induced skin blister as an in vivo model of inflammation Biologic response modifiers to decrease inflammation: Focus on infection risks.Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability.Novel Human Three-Domain Antibody Fragments Against sTNFα as Well as tmTNFα with High Affinity Generated by the Combination of Ribosome Display and E. coli Expression System.p53 mediates TNF-induced epithelial cell apoptosis in IBD.Evaluation of the physicochemical and functional stability of diluted REMSIMA® upon extended storage--A study compliant with NHS (UK) guidance.Inhibition of Fas-Fas ligand interaction attenuates microvascular hyperpermeability following hemorrhagic shock.Chronic pulmonary LPS tolerance induces selective immunosuppression while maintaining the neutrophilic response.Complement 5a receptor inhibition improves renal allograft survival.Combined Intraperitoneal and Intrathecal Etanercept Reduce Increased Brain Tumor Necrosis Factor-Alpha and Asymmetric Dimethylarginine Levels and Rescues Spatial Deficits in Young Rats after Bile Duct Ligation.Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group.Molecular correlates and prognostic value of tmTNF-α expression in colorectal cancer of 5-Fluorouracil-Based Adjuvant Therapy Activation of apoptosis by 1-hydroxy-5,7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos.Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor

P2860

Q21202854-C5BD786C-69A4-4D3D-90F4-E087B5D6B655 Q26767247-6D5FA625-3E7D-4C74-936A-C93F44C22846 Q26768280-A4AAE8BF-B903-42CF-A9D1-A5AE491FE4B6 Q26783012-8C733943-7F03-47E4-B176-A88B2EC13D1D Q27022179-31D70246-D537-4A06-825E-05473502BE7D Q27030762-7F34EC96-A80F-4894-9F20-5F687D348FF5 Q27687421-994271FE-0AC9-4377-A689-D6CCCEBD493A Q30832987-FD4B9A85-817A-4C11-8634-38184B7972EE Q33527432-3BB1CAFD-55A0-410C-A9AB-1ED74E3F4FC1 Q33576859-CE60A1BB-8CD6-433D-99E4-5945F987C5DF Q33695285-A16DF0E1-A6E4-4BAF-9588-5ED978DA3C04 Q33873538-93E21DFF-91E6-498C-8513-3A1F1FB2EDB5 Q33905516-6F79BD9C-3C12-4E58-AE37-76AA8C17C9C4 Q33912625-516CE13F-A5E6-47B1-8015-9C8B683EC2F2 Q33923508-1BE1430D-AD7B-4F88-8CA5-531916E020FC Q34032964-6A7ABAAD-0FDE-401E-A765-BB39A41ADA65 Q34154042-423469AE-27D0-4B48-B323-AF5EDA7F534B Q34157182-A0866578-E013-4C32-8BE2-A52362ECAA8F Q34367861-863312CC-7DE9-4C95-8477-86571F4B5D39 Q34519187-4D332BC0-58B4-44C0-BD75-336371A6073A Q34533855-71D5A194-43F3-4740-9B24-5A1B386BFB6A Q35069265-398B7EA1-6C1A-4A3C-A7D5-8E99950AA416 Q35137792-28653F96-BA89-4340-920E-B5494EDD6C3F Q35232352-430655AC-B980-4276-808C-9CB53C4D03C3 Q35415815-48E5299F-5A44-4012-9061-8ED8C4261BC2 Q35579308-602DED14-A4FD-4357-B4C6-2EB119F83598 Q35629765-6021D42A-86FA-4F98-8B8D-54955B3EE18F Q35779755-C6D048D4-B554-4DE9-98B5-AF56F6DF4C55 Q35851073-FFFC81AE-253B-4692-B2BA-A277F81D3DBE Q35918691-BC60EE85-28DA-4609-857F-EE2C955B4BF8 Q36295461-CE5C07ED-A768-4BC6-82AE-475DC1D1A944 Q36394491-896AF5E5-74A4-4A60-BF3E-C3525A1DD49C Q36807253-AE7DDC5D-50D7-48A1-B876-D61AE92E4B1E Q36897545-4CBC003A-2996-40C2-B885-DF10134511CD Q36985768-9B8EDB0D-35B4-49B1-A000-0002A5FD86E3 Q37029990-11244E8E-C2C4-4C8A-8EC7-8BA5E22A7E1D Q37172804-0EFFE97F-2AE8-415B-B41E-FFFB06A5DF29 Q37187787-190F4154-864C-44F2-AB5C-02D29C69B465 Q37216528-02770071-93E3-4345-AB04-3C303D83CDD6 Q37270827-C2A15EA4-3BA4-42BD-98F2-F872369415A9

P2860

TNFalpha blockade in human diseases: mechanisms and future directions.

http://www.wikidata.org/entity/Q36536886

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

TNFalpha blockade in human diseases: mechanisms and future directions.

@ast

TNFalpha blockade in human diseases: mechanisms and future directions.

@en

type

label

TNFalpha blockade in human diseases: mechanisms and future directions.

@ast

TNFalpha blockade in human diseases: mechanisms and future directions.

@en

prefLabel

TNFalpha blockade in human diseases: mechanisms and future directions.

@ast

TNFalpha blockade in human diseases: mechanisms and future directions.

@en

P1433

Q36536886-E1C23269-7B36-45B0-B2FD-2741A96FE7E8

P1476

Q36536886-95B1BB28-288C-4AD0-BA90-8FFE7E66C518

P2093

Q36536886-2085EE7D-FEA4-46B9-B862-3DB0016BC22E

Q36536886-3D2B293E-1947-46CA-B9F9-69736274F7D7

Q36536886-54115456-A344-470D-8BF5-18A81A12CC29

Q36536886-563D01E3-9E94-41B4-A170-427C14130D80

Q36536886-5EC44546-0F7C-4442-812B-E1F59663832C

Q36536886-6E8C1461-0E83-41DA-8BFA-1BA124B2E0DD

Q36536886-6F0C7EE5-B1FC-4EA8-A9F2-740DD78F4268

Q36536886-B7B543F9-C9A7-49FC-A394-CE7355C7AE92

Q36536886-E3D2CA03-D51D-4AAB-9767-14DFBB4A7851

Q36536886-FB212227-F79D-4190-9034-4B5C20C9BA5D

P2860

Q36536886-042B905F-091E-4B31-BC3A-3D55366F3639

Q36536886-05ECED14-9F63-419F-81CE-CC7E3FF0B4E8

Q36536886-0663F064-35B5-4869-A308-33BB8FC8E93E

Q36536886-0B5BD46C-91C6-4B8C-8EBC-EC2D62BC6654

Q36536886-0F4E15DA-72CE-4B06-9B63-C38428F07C8C

Q36536886-1232CC79-C580-4682-A9B9-B513D8DE0E39

Q36536886-12703341-9DBA-47B0-8246-9BB8582E3F7C

Q36536886-1527C114-7333-4BD9-92DB-E5DE4D393D62

Q36536886-17F15216-DF78-4620-BBE4-C874CBBA29B2

Q36536886-1BB547AA-1ED7-4105-A226-231B2760F96D

P304

Q36536886-B68B0CC0-CB41-4361-BF0E-6197B57DEDD2

P31

Q36536886-2FF6AC0C-D8E1-4EF5-891A-4A44B4A946A0

P356

Q36536886-0034D5C6-10A0-4E30-BBB1-FBB9E898D6D1

P433

Q36536886-9612CB2D-7AB0-462D-97F3-EEE87DB96658

P478

Q36536886-0EF7DD71-EFC2-4E68-A34D-547380A94DE5

P577

Q36536886-83B1CFB4-1406-44D2-92FF-C79713C507A2

P5875

Q36536886-C6B7EF92-A338-4627-95F3-3DB35E4F8DEF

P698

Q36536886-D4884065-C1A3-49B2-9F27-F26DFA60188F

P932

Q36536886-3AFC0F3B-CECD-4EA6-AA76-0F49556F22AE

P356

J.CLIM.2007.08.013

P1433

Clinical Immunology

P1476

TNFalpha blockade in human diseases: mechanisms and future directions.

@en

P2093

David Gjertson

http://www.w3.org/2001/XMLSchema#string

David Ziring

http://www.w3.org/2001/XMLSchema#string

Elaine Reed

http://www.w3.org/2001/XMLSchema#string

Jan Lin

http://www.w3.org/2001/XMLSchema#string

Jonathan Braun

http://www.w3.org/2001/XMLSchema#string

Maida Wong

http://www.w3.org/2001/XMLSchema#string

Ram Raj Singh

http://www.w3.org/2001/XMLSchema#string

Sheetal Desai

http://www.w3.org/2001/XMLSchema#string

Sungjin Kim

http://www.w3.org/2001/XMLSchema#string

Yael Korin

http://www.w3.org/2001/XMLSchema#string

P2860

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis

CDP-870 (certolizumab) in rheumatoid arthritis

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

Mouse models for the study of Crohn's disease.

TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis.

Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

P304

121-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLIM.2007.08.013

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5929458

http://www.w3.org/2001/XMLSchema#string

P698

17916444

http://www.w3.org/2001/XMLSchema#string

P932

2291518

http://www.w3.org/2001/XMLSchema#string